Sign In
Buy R
$260.38
+2.32 (+0.90%)
At Close: Jun 03, 2026
MedMira Receives Investigational Testing Authorization for its Multiplo(R) Complete Syphilis (TP/nTP) Antibody Test
06:00pm, Thursday, 09'th Jan 2025
HALIFAX, NS / ACCESSWIRE / January 9, 2025 / Today, MedMira Inc. (MedMira) (TSXV:MIR) announced that its received investigational testing authorization (ITA) from Health Canada to begin clinical trial
Ryder System: The Ride That Keeps On Delivering
02:33pm, Thursday, 09'th Jan 2025
Ryder System's shares have surged significantly, outperforming the S&P 500, and remain attractively priced, justifying a continued 'buy' rating. The company's revenue and operating revenue have shown
Tenon Medical(R) to Host Meetings During the 2025 J.P. Morgan Healthcare Conference in San Francisco
08:00am, Thursday, 09'th Jan 2025
LOS GATOS, CA / ACCESSWIRE / January 9, 2025 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering from certain Sacroiliac Joint (SIJ) diso
License Agreement Expands Zomedica's Portfolio with Revolutionary Hemostatic Technology ANN ARBOR, MI / ACCESSWIRE / January 7, 2025 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"),
Here's Why Investors Should Give Ryder System Stock a Miss Now
12:26pm, Friday, 03'rd Jan 2025
R is grappling with a downturn in freight market conditions, hurting its prospects. Escalated operating expenses are a major headwind.
Elite Pharmaceuticals Announces Commercial Launch of Generic Vyvanse(R)
07:00am, Thursday, 26'th Dec 2024
Northvale, New Jersey--(Newsfile Corp. - December 26, 2024) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company developing niche generic products
MedMira receives Health Canada approval for its Multiplo(R) Rapid (TP/HIV) Test for Syphilis and HIV
12:00pm, Tuesday, 24'th Dec 2024
HALIFAX, NS / ACCESSWIRE / December 24, 2024 / MedMira Inc. (MedMira) (TSXV:MIR) announced today that it has received today, on December 24, 2024, the approval from Health Canada for its Multiplo® Ra
Zomedica Launches Two New Quantitative Assays on the TRUFORMA(R) Platform: Canine NT-proBNP and Progesterone
06:30am, Monday, 23'rd Dec 2024
With the addition of these two new assay launches, Zomedica has added 8 new assays in the past 18 months to the rapidly growing TRUFORMA Platform ANN ARBOR, MI / ACCESSWIRE / December 23, 2024 / Zomed
Dalrada Financial Corporation's Deposition Technology Makes Spectroptix(R) Available for Advance Ordering
08:00am, Tuesday, 17'th Dec 2024
Deptec's plasma spectrometer is primed to play an integral role in the booming semiconductor manufacturing and thin-film sectors. SAN DIEGO, CA / ACCESSWIRE / December 17, 2024 / Dalrada Financial Cor
Ryder Names Chief Operating Officer and New Chief Financial Officer
04:35pm, Monday, 16'th Dec 2024
MIAMI--(BUSINESS WIRE)-- #RyderEverbetter--Ryder appoints industry and company veterans to top operations and financial roles, naming chief operating officer and new chief financial officer.
Edge Total Intelligence Recognized in the 2024 Gartner(R) Market Guide for Digital Twin of an Organization Platforms
03:01am, Thursday, 12'th Dec 2024
Arlington, Virginia--(Newsfile Corp. - December 12, 2024) - Edge Total Intelligence Inc. (TSXV: CTRL) (OTCQB: UNFYF) (FSE: Q5I) ("edgeTI", "Company"), a leading provider of real-time Digital Operation
GMG's THERMAL-XR(R) Demonstrates Potential for Electronics Heat Sink Miniaturization and Efficiency
08:15am, Wednesday, 11'th Dec 2024
Brisbane, Queensland, Australia--(Newsfile Corp. - December 11, 2024) - Graphene Manufacturing Group Ltd. (TSXV: GMG) (OTCQX: GMGMF) ("GMG" or the "Company") is pleased to provide a business update on
Neos S&P 500(R) High Income ETF Harnesses the Power of Options
06:55am, Wednesday, 11'th Dec 2024
Neos S&P 500(R) High Income ETF BATS: SPYI is an interesting play on the S&P 500 benchmarked to the CBOE's S&P 500 Buy-Write index. The Buy-Write index tracks potential returns from an S&P 500-oriente
Protium Clean Energy Corp. Announces Appointment of John Ryder to Advisory Board
08:19am, Tuesday, 10'th Dec 2024
Toronto, Ontario--(Newsfile Corp. - December 10, 2024) - Protium Clean Energy Corp. (CSE: GRUV) (FSE: G071), a leading resource company focused on clean energy and sustainable resource development, is
Theralase(R) Launches Three New Clinical Study Sites in USA
08:05am, Monday, 09'th Dec 2024
Associated Medical Professionals of NY, Urology of Indiana and Central Ohio Urology Group are the latest three US-based study sites for clinical research of Theralase®'s bladder cancer treatment TORO
